InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Garofalo, Elizabeth. Director active across 1 company, notably Xenon Pharmaceuticals Inc.. Aggregated, 4 filings have been recorded. Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Elizabeth Garofalo has 4 filings in total. The 4 sampled filings concern Xenon Pharmaceuticals Inc. (XNAS), where she is Director of Issuer. The modal transaction nature is 57 - Exercise of rights, and the sampled filings run from 2026-06-05 to 2026-06-05, with buy and sell amounts of 0.